THE IMPACT OF BOTULINUM TOXIN ON VOICE QUALITY AFTER LARYNGECTOMY
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4804Keywords:
Tracheoesophageal Speech, Total Laryngectomy, Pharyngoesophageal Segment, Botulinum Toxin, Voice RehabilitationAbstract
Objectives: Tracheoesophageal (TE) speech is the preferred method of voice rehabilitation after total laryngectomy; however, its effectiveness is frequently compromised by pharyngoesophageal spasm (PES). The objective of this review was to evaluate the anatomical, physiological, diagnostic, and therapeutic evidence supporting the use of botulinum toxin (BTX) for the management of PES-related TE voice dysfunction.
Methods: A narrative review of peer-reviewed English-language literature was conducted using PubMed and major scientific databases. Studies addressing pharyngoesophageal segment physiology, diagnostic assessment of PES, and clinical, acoustic, aerodynamic, and perceptual outcomes following BTX injection in laryngectomized patients were qualitatively synthesized.
Results: Across heterogeneous study designs, PES was consistently identified as a primary barrier to effective TE phonation, characterized by elevated intraluminal pressure, restricted segmental aperture, and impaired vibratory behavior. BTX injection reliably reduced PE segment hypertonicity, resulting in improved airflow dynamics, enhanced vibratory regularity, increased maximum phonation time, and improved acoustic stability. Perceptual assessments and patient-reported outcomes demonstrated significant gains in speech intelligibility, vocal effort, communicative participation, and quality of life. Additional benefits included improved prosthesis function and longevity. Adverse effects were mild, transient, and infrequent.
Conclusions: Botulinum toxin is a safe, minimally invasive, and physiologically targeted treatment for PES-related TE speech dysfunction. The convergent evidence supports its role as a first-line or adjunctive therapy for restoring voice quality and communication after total laryngectomy.
References
Agrawal, N., & Goldenberg, D. (2008). Primary and salvage total laryngectomy. Otolaryngologic Clinics of North America, 41(4), 771–780. https://doi.org/10.1016/j.otc.2008.02.001
Arenaz Búa, B., Pendleton, H., Westin, U., & Rydell, R. (2018). Voice and swallowing after total laryngectomy. Acta Oto-Laryngologica, 138(2), 170–174. https://doi.org/10.1080/00016489.2017.1384056
Bandi, F., Chu, F., Zurlo, V., Di Natale, V., Zorzi, S., Pietrobon, G., De Berardinis, R., Tagliabue, M., & Ansarin, M. (2024). Unlocking tracheoesophageal speech from pharyngoesophageal spasm: Preliminary results of a videofluoroscopic-guided botulinum toxin A injection technique. European Archives of Oto-Rhino-Laryngology, 281(4), 1885–1893. https://doi.org/10.1007/s00405-024-08448-9
Blitzer, A., Komisar, A., Baredes, S., Brin, M. F., & Stewart, C. (1995). Voice failure after tracheoesophageal puncture: Management with botulinum toxin. Otolaryngology–Head and Neck Surgery, 113(6), 668–670. https://doi.org/10.1016/S0194-5998(95)70002-1
Braun, T., Gürkov, R., Hempel, J. M., Berghaus, A., & Krause, E. (2010). Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology. European Archives of Oto-Rhino-Laryngology, 267(12), 1963–1967. https://doi.org/10.1007/s00405-010-1305-0
Caetano, G., Morgado, F., Póvoa, J., & Branquinho, F. (2025). Improving voice quality in laryngectomy patients with botulinum toxin A. Acta Otorrinolaringológica Española (English Edition), 76(3), 512222. https://doi.org/10.1016/j.otoeng.2025.512222
Chaukar, D. A., Sayed, S. I., Shetty, N. S., Kulkarni, A. V., Kulkarni, S. S., Deshmukh, A. D., & D’Cruz, A. K. (2013). Ultrasound-guided botulinum toxin injection: A simple in-office technique to improve tracheoesophageal speech in postlaryngectomy patients. Head & Neck, 35(4), E122–E125. https://doi.org/10.1002/hed.21961
Chone, C. T., Gripp, F. M., Spina, A. L., & Crespo, A. N. (2005). Primary versus secondary tracheoesophageal puncture for speech rehabilitation in total laryngectomy: Long-term results with indwelling voice prosthesis. Otolaryngology–Head and Neck Surgery, 133(1), 89–93. https://doi.org/10.1016/j.otohns.2005.02.014
Chone, C. T., Seixas, V. O., Andreollo, N. A., Quagliato, E., Barcelos, I. H., Spina, A. L., & Crespo, A. N. (2009). Computerized manometry use to evaluate spasm in the pharyngoesophageal segment in patients with poor tracheoesophageal speech before and after treatment with botulinum toxin. Brazilian Journal of Otorhinolaryngology, 75(2), 182–187. https://doi.org/10.1016/S1808-8694(15)30776-X
Chone, C. T., Teixeira, C., Andreollo, N. A., Spina, A. L., Barcellos, I. H., Quagliato, E., & Crespo, A. N. (2008). Botulinum toxin in speech rehabilitation with voice prosthesis after total laryngectomy. Brazilian Journal of Otorhinolaryngology, 74(2), 230–234. https://doi.org/10.1016/S1808-8694(15)31093-4
Cocuzza, S., Bonfiglio, M., Grillo, C., Maiolino, L., Malaguarnera, M., Martines, F., & Serra, A. (2013). Post-laryngectomy speech rehabilitation outcome in elderly patients. European Archives of Oto-Rhino-Laryngology, 270(6), 1879–1884. https://doi.org/10.1007/s00405-013-2430-3
Dworkin, J. P., Meleca, R. J., Zormeier, M. M., Simpson, M. L., Garfield, I., Jacobs, J. R., & Mathog, R. H. (1998). Videostroboscopy of the pharyngoesophageal segment in total laryngectomees. The Laryngoscope, 108(12), 1773–1781. https://doi.org/10.1097/00005537-199812000-00003
Hamaker, R. C., & Blom, E. D. (2003). Botulinum neurotoxin for pharyngeal constrictor muscle spasm in tracheoesophageal voice restoration. The Laryngoscope, 113(9), 1479–1482. https://doi.org/10.1097/00005537-200309000-00010
Hoffman, H. T., Fischer, H., VanDenmark, D., Peterson, K. L., McCulloch, T. M., Karnell, L. H., & Funk, G. F. (1997). Botulinum neurotoxin injection after total laryngectomy. Head & Neck, 19(2), 92–97. https://doi.org/10.1002/(SICI)1097-0347(199703)19:2
<92::AID-HED2>3.0.CO;2-P
Iwai, M., Ando, S., & Sato, K. (2023). The process of reacquiring new vocalization in total laryngectomy patients with head and neck cancer: A qualitative study. Asia-Pacific Journal of Oncology Nursing, 11(3), 100362. https://doi.org/10.1016/j.apjon.2023.100362
Iype, E. M., Janardhanan, D., Patil, S., Suresh, S., Varghese, B. T., & Thomas, S. (2020). Voice rehabilitation after laryngectomy: A regional cancer centre experience and review of literature. Indian Journal of Otolaryngology and Head & Neck Surgery, 72(4), 518–523. https://doi.org/10.1007/s12070-019-01707-w
Kazemi, R. J., Prince, A. D. P., Casper, K. A., Spector, M. E., Smith, J. D., & Prince, M. E. P. (2024). Retrospective exploration of botulinum toxin injection for pharyngoesophageal segment dysfunction post-laryngectomy. OTO Open, 8(4), e181. https://doi.org/10.1002/oto2.181
Köybaşioğlu, A., Oz, O., Uslu, S., Ileri, F., Inal, E., & Unal, S. (2003). Comparison of pharyngoesophageal segment pressure in total laryngectomy patients with and without pharyngeal neurectomy. Head & Neck, 25(8), 617–623. https://doi.org/10.1002/hed.10265
Krause, E., Hempel, J. M., & Gürkov, R. (2009). Botulinum toxin A prolongs functional durability of voice prostheses in laryngectomees with pharyngoesophageal spasm. American Journal of Otolaryngology, 30(6), 371–375. https://doi.org/10.1016/j.amjoto.2008.07.008
Lightbody, K. A., Wilkie, M. D., Kinshuck, A. J., Gilmartin, E., Lewis-Jones, H., Jones, T. M., & Lancaster, J. (2015). Injection of botulinum toxin for the treatment of post-laryngectomy pharyngoesophageal spasm-related disorders. Annals of the Royal College of Surgeons of England, 97(7), 508–512. https://doi.org/10.1308/rcsann.2015.0011
Maniaci, A., Lavalle, S., Mayo-Yanez, M., Parisi, F. M., & Cocuzza, S. (2024). Videofluoroscopy-guided botulinum toxin for pharyngoesophageal spasm: A promising advance in laryngectomy rehabilitation. European Archives of Oto-Rhino-Laryngology, 281(6), 3305–3306. https://doi.org/10.1007/s00405-024-08554-8
Meleca, R. J., Dworkin, J. P., Zormeier, M. M., Simpson, M. L., Shibuya, T., & Mathog, R. H. (2000). Videostroboscopy of the pharyngoesophageal segment in laryngectomy patients treated with botulinum toxin. Otolaryngology–Head and Neck Surgery, 123(1), 38–43. https://doi.org/10.1067/mhn.2000.106400
Sparks, F., Coffey, M., Dipper, L., Morgan, S., & Hilari, K. (2023). Tracheoesophageal voice therapy in postlaryngectomy rehabilitation: A systematic review. Journal of Voice. Advance online publication. https://doi.org/10.1016/j.jvoice.2023.10.033
Terrell, J. E., Lewin, J. S., & Esclamado, R. (1995). Botulinum toxin injection for postlaryngectomy tracheoesophageal speech failure. Otolaryngology–Head and Neck Surgery, 113(6), 788–791. https://doi.org/10.1016/S0194-5998(95)70023-4
van Sluis, K. E., van der Molen, L., van Son, R. J. J. H., Hilgers, F. J. M., Bhairosing, P. A., & van den Brekel, M. W. M. (2018). Objective and subjective voice outcomes after total laryngectomy: A systematic review. European Archives of Oto-Rhino-Laryngology, 275(1), 11–26. https://doi.org/10.1007/s00405-017-4790-6
Watson, N. A., Miller, B., Siddiqui, Z., Karagama, Y., & Gibbins, N. (2020). The therapeutic use of botulinum toxin injections for conditions affecting the head and neck. Current Otorhinolaryngology Reports, 8, 1–10. https://doi.org/10.1007/s40136-020-00305-7
Zalvan, C. H. (2004). Using botulinum toxin therapy in the laryngopharynx. Operative Techniques in Otolaryngology–Head and Neck Surgery, 15(2), 86–89.
Zenga, J., Goldsmith, T., Bunting, G., & Deschler, D. G. (2018). State of the art: Rehabilitation of speech and swallowing after total laryngectomy. Oral Oncology, 86, 38–47. https://doi.org/10.1016/j.oraloncology.2018.08.023
Zhang, T., Cook, I., Szczęśniak, M., Maclean, J., Wu, P., Nguyen, D. D., & Madill, C. (2019). The relationship between biomechanics of the pharyngoesophageal segment and tracheoesophageal phonation. Scientific Reports, 9(1), 9722. https://doi.org/10.1038/s41598-019-46223-7
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Natalia Hariasz, Paulina Malon, Karol Śliwa, Anita Pieńkowska, Aleksandra Trojańska, Nel Geworkian, Martyna Pietz, Anita Szymańska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

